European experts fear that routine vCJD (variant Creuzfeldt Jacob disease) blood test could deter donors
This article was originally published in Clinica
Screening blood donations for variant Creuzfeldt Jacob disease (vCJD) when a suitable assay becomes available could lead to a significant lack of donors, the European Commission's Scientific Committee on Medicinal Products and Medical Devices (SCMPMD) has warned.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.